Press Releases
Veristat to Assist on Adaptive Enrichment Trial for Verastem’s Defactinib in Mesothelioma
Veristat LLC. a leading Boston-based clinical research organization today announced its advisory role on the implementation of an adaptive enrichment trial design for Verastem...
News
Statins being overprescribed for growing number of kidney disease patients
A new analysis concludes that large numbers of patients in advanced stages of kidney disease are inappropriately being prescribed statins to lower their cholesterol...
Press Releases
Oncodesign and Banook Central Imaging sign a collaboration agreement to develop biomarkers in clinical imaging
Oncodesign, a contract research laboratory dedicated to the discovery of new anticancer therapies, and Banook Central Imaging, a company specializing in the centralized reading...
Press Releases
Almac and Queen’s University, Belfast announce £13 million investment in Cancer Research
Almac Discovery has announced a £13million partnership with the Centre for Cancer Research and Cell Biology (CCRCB) at Queen’s University Belfast (QUB) to accelerate...
News
SAVOR-TIMI 53 sets new standard for cardiovascular outcome trials in diabetes
Uncertainty persists regarding whether drugs that lower sugar reduce the risk of heart attack, with some concerns that diabetes drugs may actually raise the...
Press Releases
PharmaEngine Announces Achieving Patient Enrollment Goal in the Phase III Metastatic Pancreatic Cancer Study of PEP02
PharmaEngine Inc. announced today that together with PharmaEngine’s partner Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) we reach the goal of patient enrollment in the global...
News
Novartis holds annual healthcare entrepreneur competition
Novartis has invited 60 selected students from leading international universities in 21 countries to its headquarters in Switzerland for the International Biotechnology Leadership Camp...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















